Biologics Top Stories UK’s MHRA Accepts Biosplice’s Application for Lorecivivint (LOR) in Knee Osteoarthritis and Begins Assessment byNoah SimmonsSeptember 8, 2026
Extremities AAOS Releases Clinical Practice Guideline for Management of Ankle Osteoarthritis byBree MillerJuly 2, 2026
Recon New Published Five-Year Data Shows Exceptional Results for Knee Osteoarthritis Patients Treated with the MISHA® Knee System byJosh SandbergJune 24, 2026
Recon Sports Medicine Nonsurgical Procedure Provides Lasting Relief for Knee Pain byJosh SandbergJune 16, 2026
Biologics Regulatory Sports Medicine Organogenesis Completes Rolling Submission of Biologics License Application for ReNu® byTim AllenApril 29, 2026
Financial Recon Robotics Hip Replacement Market to Reach US$ 11.4 Billion by 2033 Driven by Aging Population, Rising Osteoarthritis, and Robotic-Assisted Surgery Says Astute Analytica byJosh SandbergFebruary 2, 2026
Regulatory Sports Medicine Top Stories FDA Approves Updated Label for Miach Orthopaedics’ BEAR® Implant to Include Significantly Lower Risk of Osteoarthritis byJosh SandbergJanuary 14, 2026
Biologics Extremities Spine Pacira Biosciences Joins PROBE Consortium to Transform Osteoarthritis Research and Care byJosh SandbergDecember 19, 2025
Regulatory Sports Medicine Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain byTim AllenDecember 15, 2025
Recon New Lancet-Published Study Shows AI-Powered Decision Support Tool Improves Decision Quality and Patient Outcomes byTim AllenDecember 10, 2025
